AIBuzzHub
Signal Brief
Home/Events/Science Corporation implants PRIMA vision-restoring chip in first Stargardt disease patient

Science Corporation implants PRIMA vision-restoring chip in first Stargardt disease patient

Confirmed
Confidence
90%
Impact: 80%
Updated Oct 14

Consensus Brief

Science Corporation has successfully implanted its PRIMA vision-restoring chip into its first patient suffering from Stargardt disease, which leads to the gradual loss of central vision. The procedure took place at the Sydney Eye Hospital, marking a significant step in the company's efforts to develop brain-computer interface technologies for medical applications. The device aims to restore vision by simulating photoreceptor function in the eye.

Sourced from
TechCrunchT2TechCrunchT2TechCrunchT2TechCrunchT2+29 more
Primary: TechCrunch

What Changed Since Last Update

Oct 14

New corroborating source added: TechCrunch published an update on Tue, 13 Oc ("Science Corporation implants its vision-restoring chip in its first Stargardt disease patient").

Claim Ledger

5 claims tracked across sources

Confirmed Fact

Approximately 150,000 people worldwide have lost vision due to Stargardt disease.

Confirmed Fact

The first patient with Stargardt disease received the PRIMA implant in May.

Confirmed Fact

The device is commercially available in Europe for patients who’ve lost their sight to geographic atrophy.

Confirmed Fact

Science Corporation was founded in 2021 after Max Hodak left Neuralink.

Official Claim

The next generation of the device is expected to be in humans in the next year.

Role-Based Impact Analysis

Source Timeline

30 sources corroborating

T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13
T2
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch·Oct 13